Cargando…
Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes
Autores principales: | Vogel, Joshua P, Ramson, Jennifer, Darmstadt, Gary L, Qureshi, Zahida P, Chou, Doris, Bahl, Rajiv, Oladapo, Olufemi T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681658/ https://www.ncbi.nlm.nih.gov/pubmed/36400080 http://dx.doi.org/10.1016/S2214-109X(22)00434-X |
Ejemplares similares
-
Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review
por: Sebastian, Elizabeth, et al.
Publicado: (2022) -
Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial
por: De Costa, Ayesha, et al.
Publicado: (2022) -
Effect of antenatal corticosteroid administration-to-birth interval on maternal and newborn outcomes: a systematic review
por: McDougall, Annie R.A., et al.
Publicado: (2023) -
Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials
por: Vogel, Joshua P, et al.
Publicado: (2017) -
Tocolytic Therapy Inhibiting Preterm Birth in High-Risk Populations: A Systematic Review and Meta-Analysis
por: Yamaji, Noyuri, et al.
Publicado: (2023)